Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000253383 | SCV000320563 | likely benign | Cardiovascular phenotype | 2015-12-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Illumina Laboratory Services, |
RCV000275587 | SCV000377878 | uncertain significance | Timothy syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000311551 | SCV000377879 | uncertain significance | Brugada syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001705399 | SCV000520594 | likely benign | not provided | 2021-06-30 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000864490 | SCV001005297 | likely benign | Long QT syndrome | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001705399 | SCV004132345 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | CACNA1C: BP4, BP7 |